May 2021
Macquarie executive earns $5m more than CEO
An unprecedented Texan cold snap and the galloping recovery from the pandemic helped deliver the eye-watering pay packet to little-known Macquarie veteran Nick O’Kane.
- Michael Roddan
November 2020
The people who will give us QE
Nine board members are about to make the Reserve Bank of Australia's biggest decision in decades.
- Matthew Cranston
July 2020
- Analysis
- Growth Nation
Sector outperformance set to continue for a long time
Healthcare stocks have earned a reputation as safe investments, and it's a theme that could extend into this decade.
- Mark Eggleton
September 2019
- Exclusive
- Biotech
Aussie biotech gets US grant as it aims to tackle opiate crisis
High-profile Aussie businessmen, including Allan Moss and Paul Little, have thrown their money behind Kinoxis Therapeutics, which was spun out of the University of Sydney.
- Carrie LaFrenz